Medicare Enrolled
Dr. Samerah Razuman, M.D.
Nephrology · Fort Pierce, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Razuman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Razuman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Razuman
Dr. Samerah Razuman is a nephrology specialist in Fort Pierce, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Razuman performed 3,809 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Razuman received a total of $8,223 from 39 pharmaceutical and/or device companies across 319 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Razuman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 9% volume in FL
$8,223 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,809
Medicare services
Top 9% in FL for nephrology
Not available
Unique patients (not deduplicated)
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,278 | $97 | $233 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
665 | $76 | $260 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
305 | $137 | $378 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
215 | $275 | $723 |
| Home dialysis services per month Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older. |
184 | $224 | $600 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
177 | $31 | $54 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
135 | $48 | $88 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
129 | $38 | $67 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
124 | $38 | $65 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
114 | $64 | $153 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
107 | $233 | $601 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
88 | $38 | $66 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
85 | $176 | $447 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
61 | $125 | $342 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
32 | $11 | $28 |
| Dialysis procedure with evaluation A dialysis treatment that includes one evaluation. |
30 | $69 | $174 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
19 | $56 | $184 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
18 | $124 | $367 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
16 | $51 | $153 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
16 | $16 | $42 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
11 | $151 | $390 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.8% high complexity
14.9% medium
84.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,223
Total received (2018-2024)
Avg $1,175/year across 7 years
Top 10% in FL for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
319
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,978
2023
$1,736
2022
$1,816
2021
$1,529
2020
$181
2019
$400
2018
$583
Payments by company (2024)
Bayer Healthcare Pharmaceuticals Inc.
$473
Ardelyx, Inc.
$299
Amgen Inc.
$200
AstraZeneca Pharmaceuticals LP
$197
CALLIDITAS THERAPEUTICS US INC.
$159
AKEBIA THERAPEUTICS INC
$104
Vifor Pharma, Inc.
$96
Novo Nordisk Inc
$93
Lilly USA, LLC
$55
Aurinia Pharma U.S., Inc.
$53
Otsuka America Pharmaceutical, Inc.
$52
Mallinckrodt Hospital Products Inc.
$45
Travere Therapeutics, Inc.
$38
ANI Pharmaceuticals, Inc.
$34
Novartis Pharmaceuticals Corporation
$22
Fresenius USA Marketing, Inc.
$21
Baxter Healthcare
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Top 3 companies account for 49.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,077
Amgen Inc.
$1,003
Bayer Healthcare Pharmaceuticals Inc.
$852
Bayer HealthCare Pharmaceuticals Inc.
$636
Mallinckrodt Hospital Products Inc.
$581
Vifor Pharma, Inc.
$463
CALLIDITAS THERAPEUTICS US INC.
$325
Ardelyx, Inc.
$299
Takeda Pharmaceuticals U.S.A., Inc.
$258
Otsuka America Pharmaceutical, Inc.
$252
Fresenius USA Marketing, Inc.
$240
Baxter Healthcare
$215
AKEBIA THERAPEUTICS INC
$211
Aurinia Pharma U.S., Inc.
$194
Novo Nordisk Inc
$153
Horizon Therapeutics plc
$148
AMAG Pharmaceuticals, Inc.
$142
Relypsa, Inc.
$129
NxStage Medical, Inc.
$120
OPKO Pharmaceuticals, LLC
$118
Travere Therapeutics, Inc.
$96
GENZYME CORPORATION
$88
Calliditas Therapeutics US Inc.
$66
Keryx Biopharmaceuticals, Inc.
$61
ANI Pharmaceuticals, Inc.
$60
Coala Life Inc
$56
Lilly USA, LLC
$55
Shire North American Group Inc
$54
Mallinckrodt LLC
$52
GlaxoSmithKline, LLC.
$34
Horizon Pharma plc
$29
Alnylam Pharmaceuticals Inc.
$28
Daiichi Sankyo Inc.
$24
Novartis Pharmaceuticals Corporation
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Medtronic, Inc.
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
Alexion Pharmaceuticals, Inc.
$15
Ultragenyx Pharmaceutical Inc.
$12
Top 3 companies account for 35.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AURYXIA · Aranesp · Auryxia · BENLYSTA · BRILINTA · Coala Heart Monitor · Dialyzers · ELLIPSYS VASCULAR ACCESS SYSTEM · EVUSHELD · FABRAZYME · FABRY-DISEASE · FARXIGA · FERAHEME · GATTEX · IBSRELA · INJECTAFER · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LIBERTY SELECT CYCLER · LOKELMA · LUPKYNIS · NATPARA · Not Product Related · OXLUMO · Ozempic · PURIFIED CORTROPHIN GEL · Parsabiv · Rayaldee · Renal - Extraneal Solution · Renal - PD · SOLIRIS · TARPEYO · TAVNEOS · TERLIVAZ · Tavneos · Tresiba · Uloric · Vafseo · Velphoro · Veltassa · XIFAXAN · XPHOZAH 30 MG
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Nephrologists in nearby ZIP areas
23
County median income
$69,027
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA LAWNWOOD HOSPITAL
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Razuman is a clinical cardiology specialist, with above-average Medicare volume (top 9% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Razuman experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Razuman performed 1,278 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Razuman receive payments from pharmaceutical companies?
Yes. Dr. Razuman received a total of $8,223 from 39 companies across 319 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Razuman's costs compare to other nephrologists in Fort Pierce?
Dr. Razuman's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Razuman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Fort Pierce
Browse nephrologists in Fort Pierce ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in FL
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in FL
Which FL nephrologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Bayer Healthcare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer Healthcare Pharmaceuticals Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology